Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Aggressive Hybrid Fund median (46 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Edelweiss Aggressive Hybrid Fund |
|---|---|
| 08 Jan 2013 | ₹100.00 |
| 26 Feb 2014 | ₹104.32 |
| 17 Apr 2015 | ₹153.22 |
| 04 Jun 2016 | ₹147.12 |
| 23 Jul 2017 | ₹159.75 |
| 11 Sep 2018 | ₹168.73 |
| 30 Oct 2019 | ₹173.73 |
| 17 Dec 2020 | ₹176.86 |
| 05 Feb 2022 | ₹212.12 |
| 26 Mar 2023 | ₹203.47 |
| 13 May 2024 | ₹263.31 |
| 02 Jul 2025 | ₹293.14 |
| 20 Aug 2026 | ₹281.69 |
| Metric | Edelweiss · Direct · IDCW NAV ₹33.24 High risk ★★★☆☆ | Category median Aggressive Hybrid Fund · 46 funds |
|---|---|---|
| -2.61% | -0.13% | |
| +7.39% | +8.71% | |
| +6.90% | +9.07% | |
| +6.24% | +6.41% | |
| +7.91% | +8.71% | |
| +5.79% | — | |
| +8.00% | +9.75% | |
| +7.45% | +10.21% | |
| +7.64% | +7.64% | |
| Risk | ||
| 10.82% | 11.39% | |
| 0.08 | 0.19 | |
| 0.11 | 0.26 | |
| -29.52% | -30.66% | |
| Nifty 50 | — | |
| -0.45% | +0.53% | |
| 0.79 | 0.79 | |
| 80.9% | 83.6% | |
| 75.7% | 66.2% | |
| 0.77% | 1.10% | |
| ₹3,643Cr | ₹701.99Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 189% | 37% | |
| Bhavesh Jain · 10.9y | — | |
| 08 Jan 2013 | — | |
| 91 | — | |
| 26.9% | — | |
| 1.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.